This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-02-09 CDAMG Conference Call"
Jump to navigation
Jump to search
Lisa Nelson (talk | contribs) (Created page with "back to [http://wiki.hl7.org/index.php?title=CDA_Management_Group CDA Management Group main page] {|border="1" cellpadding="2" cellspacing="0" <!---==========================...") |
Lisa Nelson (talk | contribs) |
||
Line 12: | Line 12: | ||
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 CDAMG Minutes''' <br/> | | colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 CDAMG Minutes''' <br/> | ||
'''Location: ''' Pelican - Riverside Bldg. | '''Location: ''' Pelican - Riverside Bldg. | ||
− | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018- | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-02-09'''<br/> '''Time: 2:00 PM (ET)''' |
|- | |- | ||
| colspan="1" align="right"|'''Facilitator''' | | colspan="1" align="right"|'''Facilitator''' | ||
Line 24: | Line 24: | ||
{|border="1" cellpadding="2" cellspacing="0" | {|border="1" cellpadding="2" cellspacing="0" | ||
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee''' | | border="1" cellpadding="2" colspan="1" align="left"|'''Attendee''' | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
| '''Name''' | | '''Name''' | ||
Line 155: | Line 50: | ||
| || Linda Michaelsen | | || Linda Michaelsen | ||
|- | |- | ||
− | ||| Dale Nelson | + | | || Dale Nelson |
|- | |- | ||
| || Lisa Nelson | | || Lisa Nelson | ||
Line 175: | Line 70: | ||
| | | | | | ||
========================================================---> | ========================================================---> | ||
− | ===Agenda=== | + | ===Agenda & Minutes=== |
+ | * Welcome | ||
*Agenda review | *Agenda review | ||
− | *Approve Minutes of [[2018-01- | + | *Approve Minutes of [[2018-01-29_CDAMG_WGM]] |
*Review items | *Review items | ||
− | **[http://wiki.hl7.org/images/ | + | **[http://wiki.hl7.org/images/c/c7/20180208_HL7_PSS_CDA_XSL_Update_for_CDA_Release_2-1.docx CDA R2.1 Style Sheet Creation PSS] |
*Discussion Topics | *Discussion Topics | ||
− | + | ||
**SWOT | **SWOT | ||
− | ** | + | *** Reviewed the SWOT |
− | **Discuss | + | *** Any updates as a result of activity at the WGM? |
− | ** | + | *** Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT. |
− | + | **Asset List - Status, and ongoing management. | |
− | + | ***Discuss Status/Development toward CDA Template Interchage Format | |
+ | ***Discuss Status of CDA Template Registry | ||
+ | **Discuss need for & Development of overall CDA Product Roadmap | ||
+ | **** Roadmap needs to address questions like: | ||
+ | *** Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use | ||
+ | *** Expectation for CDA R2.0 after CDA R2.1 is released? | ||
+ | *** What happens to C-CDA if CDA R2.0 is superceeded by R2.1? | ||
+ | ** Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean) | ||
+ | *** Review minutes from 2018-01-29. | ||
+ | *** Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes? | ||
+ | ** Discuss Request to add a new member to CMG representing the Quality perspective (Lisa) | ||
Revision as of 14:42, 9 February 2018
back to CDA Management Group main page
HL7 CDAMG Minutes Location: Pelican - Riverside Bldg. |
Date: 2018-02-09 Time: 2:00 PM (ET) | ||
Facilitator | Brett | Note taker(s) | Lisa |
Attendee | Name
| ||
George Dixon | |||
Jean Duteau | |||
Rick Geimer | |||
Kai Heitmann | |||
Brett Marquard | |||
Linda Michaelsen | |||
Dale Nelson | |||
Lisa Nelson | |||
Andrew Statler | |||
Quorum: Chair +3 |
Agenda & Minutes
- Welcome
- Agenda review
- Approve Minutes of 2018-01-29_CDAMG_WGM
- Review items
- Discussion Topics
- SWOT
- Reviewed the SWOT
- Any updates as a result of activity at the WGM?
- Did we add: How do we manage quality problems for IG's that have already been publishes? Add as a Weakness list in SWOT.
- Asset List - Status, and ongoing management.
- Discuss Status/Development toward CDA Template Interchage Format
- Discuss Status of CDA Template Registry
- Discuss need for & Development of overall CDA Product Roadmap
- Roadmap needs to address questions like:
- Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
- Expectation for CDA R2.0 after CDA R2.1 is released?
- What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
- Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
- Review minutes from 2018-01-29.
- Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
- Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
- SWOT
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved